Updated recommended lists of genotoxic and non-genotoxic chemicals for assessment of the performance of new or improved genotoxicity tests

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 795, Issue , 2016, Pages 7-30

  Kirkland, David ^a   Kasper, Peter ^b   Martus, Hans Jörg ^c   Müller, Lutz ^d   van Benthem, Jan ^e   Madia, Federica ^f   Corvi, Raffaella ^f  

^a Kirkland Consulting   (United Kingdom)

^b Federal Institute for Drugs and Medical Devices   (Germany)

^c NOVARTIS PHARMA AG   (Switzerland)

^d F HOFFMANN LA ROCHE LTD   (Switzerland)

^e NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^f JOINT RESEARCH CENTRE   (Italy)

Author keywords

EURL ECVAM; Genotoxicity; Improved tests; In vitro test; Reference chemicals; Reliability

Indexed keywords

ANEUGEN; CARCINOGEN; CHEMICAL AGENT; DNA;

AMES TEST; ARTICLE; CHROMOSOME ABERRATION; GENE MUTATION; GENOTOXICITY ASSAY; IN VITRO STUDY; IN VIVO STUDY; LYMPHOMA CELL; MAMMAL CELL; MICRONUCLEUS TEST; MITOGENESIS; NONHUMAN; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; ANIMAL; CHEMICALLY INDUCED; DNA DAMAGE; DRUG EFFECTS; ESCHERICHIA COLI; FACTUAL DATABASE; GROWTH, DEVELOPMENT AND AGING; HUMAN; MOUSE; MUTAGEN TESTING; PROCEDURES; RODENT; TUMOR CELL LINE;

ANEUGENS; ANIMALS; CARCINOGENS; CELL LINE, TUMOR; CHROMOSOME ABERRATIONS; DATABASES, FACTUAL; DNA DAMAGE; ESCHERICHIA COLI; HUMANS; MICE; MUTAGENICITY TESTS; RODENTIA; SENSITIVITY AND SPECIFICITY;

EID: 84950341781     PISSN: 13835718     EISSN: 18793592     Source Type: Journal    
DOI: 10.1016/j.mrgentox.2015.10.006     Document Type: Article

References (397)

1. Kirkland D., Pfuhler S., Tweats D., Aardema M., Corvi R., Darroudi F., Elhajouji A., Glatt H.-R., Hastwell P., Hayashi M., Kasper P., Kirchner S., Lynch A., Marzin D., Maurici D., Meunier J.-R., Müller L., Nohynek G., Parry J., Parry E., Thybaud V., Tice R., van Benthem J., Vanparys P., White P. How to reduce false positive results when undertaking in vitro genotoxicity testing and thus avoid unnecessary follow-up animal tests: report of an ECVAM workshop. Mutat. Res. 2007, 628:31-55.
2. Kirkland D., Aardema M., Henderson L., Müller L. Evaluation of the ability of a battery of 3 in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens. I. Sensitivity, specificity and relative predictivity. Mutat. Res. 2005, 584:1-256.
3. Fowler P., Smith R., Young J., Jeffrey L., Kirkland D., Pfuhler S., Carmichael P. Reduction of misleading (false) positive results in mammalian cell genotoxicity assays. I. Choice of cell type. Mutat. Res. 2012, 742:11-25.
4. Fowler P., Smith R., Smith K., Young J., Jeffrey L., Kirkland D., Pfuhler S., Carmichael P. Reduction of misleading (false) positive results in mammalian cell genotoxicity assays. II. Importance of accurate toxicity measurement. Mutat. Res. 2012, 747:104-117.
5. Kirkland D., Kasper P., Müller L., Corvi R., Speit G. Recommended lists of genotoxic and non-genotoxic chemicals for assessment of the performance of new or improved genotoxicity tests: a follow-up to an ECVAM workshop. Mutat. Res. 2008, 653:99-108.
6. Birrell L., Cahill P., Hughes C., Tate M., Walmsley R.M. GADD45a-GFP GreenScreen HC assay results for the ECVAM recommended lists of genotoxic and non-genotoxic chemicals for assessment of new genotoxicity tests. Mutat. Res. 2010, 695:87-95.
7. Mizota T., Ohno K., Yamada T. Validation of a genotoxicity test based on p53R2 gene expression in human lymphoblastoid cells. Mutat. Res. 2011, 724:76-85.
8. Berthelot-Ricou A., Perrin J., Di Giorgio C., De Meo M., Botta A., Courbiere B. Comet assay on mouse oocytes: an improved technique to evaluate genotoxic risk on female germ cells. Fertil. Steril. 2011, 95:1452-1457.
9. Hendriks G., Atallah M., Morolli B., Calléja F., Ras-Verloop N., Huijskens I., Raamsman M., van de Water B., Vrieling H. The ToxTracker assay: novel GFP reporter systems that provide mechanistic insight into the genotoxic properties of chemicals. Toxicol. Sci. 2012, 125:285-298.
10. Zwart E.P., Schaap M.M., van den Dungen M.W., Braakhuis H.M., White P.A., Steeg H.V., van Benthem J., Luijten M. Proliferating primary hepatocytes from the pUR288 lacZ plasmid mouse are valuable tools for genotoxicity assessment in vitro. Environ. Mol. Mutagen. 2012, 53:376-383.
11. Rajakrishna L., Krishnan Unni S., Subbiah M., Sadagopan S., Nair A.R., Chandrappa R., Sambasivam G., Sukumaran S.K. Validation of a human cell based high-throughput genotoxicity assay 'Anthem's genotoxicity screen' using ECVAM recommended lists of genotoxic and non-genotoxic chemicals. Toxicol. in Vitro 2014, 28:46-53.
12. Ireno I.C., Baumann C., Stöber R., Hengstler J.G., Wiesmüller L. Fluorescence-based recombination assay for sensitive and specific detection of genotoxic carcinogens in human cells. Arch. Toxicol. 2014, 88:1141-1159.
13. Bryce S.M., Bemis J.C., Mereness J.A., Spellman R.A., Moss J., Dickinson D., Schuler M.J., Dertinger S.D. Interpreting in vitro micronucleus positive results: simple biomarker matrix discriminates clastogens, aneugens, and misleading positive agents. Environ. Mol. Mutagen. 2014, 55:542-555.
14. Le Hegarat L., Dumont J., Josse R., Huet S., Lanceleur R., Mourot A., Poul J.-M., Guguen-Guillouzo C., Guillouzo A., Fessard V. Assessment of the genotoxic potential of indirect chemical mutagens in HepaRG cells by the comet and the cytokinesis-block micronucleus assays. Mutagenesis 2010, 25:555-560.
15. Smart D.J., Ahmedi K.P., Harvey J.S., Lynch A.M. Genotoxicity screening via the γH2AX by flow assay. Mutat. Res. 2011, 715:25-31.
16. Westerink W.M.A., Stevenson J.C.R., Horbach G.J., Schoonen W.G. The development of RAD51C, Cystatin A, p53 and Nrf2 luciferase-reporter assays in metabolically competent HepG2 cells for the assessment of mechanism-based genotoxicity and of oxidative stress in the early research phase of drug development. Mutat. Res. 2010, 696:21-40.
17. Khoury L., Zalko D., Audebert M. Validation of high-throughput genotoxicity assay screening using γH2AX in-cell western assay on HepG2 cells. Environ. Mol. Mutagen. 2013, 54:737-746.
18. Garcia-Canton C., Anadon A., Meredith C. Assessment of the in vitro γH2AX assay by High Content Screening as a novel genotoxicity test. Mutat. Res. 2013, 757:158-166.
19. Van der Linden S.C., von Bergh A.R.M., van Vught-Lussenburg B.M.A., Jonker L.R.A., Teunis M., Krul C.A.M., van der Burg B. Development of a panel of high-throughput reporter-gene assays to detect genotoxicity and oxidative stress. Mutat. Res. 2014, 760:23-32.
20. Lukamowicz-Rajska M., Kirsch-Volders M., Suter W., Martus H., Elhajouji A. Miniaturized flow cytometry-based in vitro primary human lymphocyte micronucleus assay-validation study. Environ. Mol. Mutagen. 2012, 53:260-270.
21. Thougaard A.V., Christiansen J., Mow T., Hornberg J.J. Validation of a high throughput flow cytometric in vitro micronucleus assay including assessment of metabolic activation in TK6 cells. Environ. Mol. Mutagen. 2014, 55:704-718.
22. Tilmant K., Gerets H.H.J., De Ron P., Cossu-Leguille C., Vasseur P., Dhalluin S., Atienzar F.A. The automated micronucleus assay for early assessment of genotoxicity in drug discovery. Mutat. Res. 2013, 751:1-11.
23. Westerink W.M., Stevenson J.C., Lauwers A., Griffioen G., Horbach G.J., Schoonen W.G. Evaluation of the Vitotox and RadarScreen assays for the rapid assessment of genotoxicity in the early research phase of drug development. Mutat. Res. 2009, 676:113-130.
24. Uno Y., Kojima H., Omori T., Corvi R., Honma M., Schechtman L.M., Tice R.R., Beevers C., De Boeck M., Burlinson B., Hobbs C.A., Kitamoto S., Kraynak A.R., McNamee J., Nakagawa Y., Pant K., Plappert-Helbig U., Priestley C., Takasawa H., Wada K., Wirnitzer U., Asano N., Escobar P., Lovell D., Morita T., Nakajima M., Ohno Y., Hayashi M. JaCVAM-organized international validation study of the in vivo rodent alkaline comet assay for detection of genotoxic carcinogens: II. Summary of definitive validation study results. Mutat. Res. 2015, 786-788:45-76.
25. Reus A.A., Reisinger K., Downs T.R., Carr G.J., Zeller A., Corvi R., Krul C.A.M., Pfuhler S. Comet assay in reconstructed 3D human epidermal skin models-investigation of intra- and inter-laboratory reproducibility with coded chemicals. Mutagenesis 2013, 28:709-720.
26. Dertinger S.D., Phonethepswath S., Avlasevich S.L., Torous D.K., Mereness J., Bryce S.M., Bemis J.C., Bell S., Weller P., Macgregor J.T. Efficient monitoring of in vivo pig-a gene mutation and chromosomal damage: summary of 7 published studies and results from 11 new reference compounds. Toxicol. Sci. 2012, 130:328-348.
27. Sakai A., Sasaki K., Hayashi K., Muramatsu D., Arai S., Endou N., Kuroda S., Poth A., Bohnenberger S., Kunkelmann T., Asakura M., Hirose H., Ishii N., Mizuhashi F., Kasamoto S., Nagai M., Pant K., SWB, ruce J.E., Sly S., Yamazaki M., Umeda N.T., anaka An international validation study of a Bhas 42 cell transformation assay for the prediction of chemical carcinogenicity. Mutat. Res. 2011, 725:57-77.
28. Greywe D., Kreutz J., Banduhn N., Krauledat M., Scheel J., Schroeder K.R., Wolf T., Reisinger K. Applicability and robustness of the hen's egg test for analysis of micronucleus induction (HET-MN): results from an inter-laboratory trial. Mutat. Res. 2012, 747:118-134.
29. Fowler P., Smith R., Smith K., Young J., Jeffrey L., Carmichael P., Kirkland D., Pfuhler S. Reduction of misleading (false) positive results in mammalian cell genotoxicity assays. III: sensitivity of human cell types to known genotoxic agents. Mutat. Res. 2014, 767:28-36.
30. L.S. Gold, The carcinogenic potency project. , 2004 (accessed 12.10.15). http://toxnet.nlm.nih.gov/cpdb/.
31. Mortelmans K., Haworth S., Lawlor T., Speck W., Tainer B., Zeiger E. Salmonella mutagenicity tests. II. Results from the testing of 270 chemicals. Environ. Mutagen. 1986, 8(Suppl. 7):1-119.
32. Morita N., Asano T., Awogi Y.F., Sasaki S., Sato H., Shimada S., Sutou T., Suzuki A., Wakata T., Sofuni M. Evaluation of the rodent micronucleus assay in the screening of IARC carcinogens (groups 1, 2A and 2B). The summary report of the 6th collaborative study by CSGMT/JEMS.MMS. Mutat. Res. 1997, 389:3-122.
33. Oesch F., Bücker M., Glatt H.R. Activation of phenanthrene to mutagenic metabolites and evidence for at least two different activation pathways. Mutat. Res. 1981, 81:1-10.
34. IARC monographs on the evaluation of the carcinogenic risk of chemicals to humans. Polynuclear aromatic compounds, Part 1, Chemical, environmental and experimental data 1983, vol. 32. International Agency for Research on Cancer, Lyon, France, December.
35. European Food Safety Authority (EFSA), Conclusion on the peer review of the pesticide risk assessment of the active substance fluometuron, EFSA Journal 9 (2011) 1958 (54 pages).
36. Zeiger E. Genotoxicity database. Handbook of Carcinogenic Potency and Genotoxicity Databases 1997, 687-729. CRC Press Inc., Boca Raton. L.S. Gold, E. Zeiger (Eds.).
37. Mitchell A.D., Auletta A.E., Clive D., Kirby P.E., Moore M.M., Myhr B.C. The L5187/tk+/- mouse lymphoma specific gene and chromosomal mutation assay. A phase III report of the U.S. Environmental Protection Agency Gene-Tox Program. Mutat. Res. 1997, 394:177-303.
38. Seifried H.E., Seifried R.M., Clarke J.J., Junghans T.B., San R.H. A compilation of two decades of mutagenicity test results with the Ames Salmonella typhimurium and L5178Y mouse lymphoma cell mutation assays. Chem. Res. Toxicol. 2006, 19:627-644.
39. Collin J.P. Cytogenetic effect of sodium cyclamate, cyclohexanone and cyclohexanol. Diabete (French) 1971, 19:215-221.
40. Lederer J., Collin J.P., Pottier-Arnould A.M., Gondry E. Cytogenetic and teratogenic action of cyclamate and its metabolites. Therapeutique 1971, 47:357-363.
41. Dyshlovoĭ V.D., Boĭko N.L., Shemetun A.M., Kharchenko T.I. Cytogenetic action of cyclohexanone. Gig Sanit. (Russian) 1981, 5:76-77.
42. De Hondt H.A., Temtamy S.A., Abd-Aziz K.B. Chromosomal studies on laboratory rats (Rattus norvegicus) exposed to an organic solvent (cyclohexanone). Egypt J. Genet. Cytol. 1983, 12:31-40.
43. Kayani M.A., Parry J.M. The detection and assessment of the aneugenic potential of selected oestrogens, progestins and androgens using the in vitro cytokinesis blocked micronucleus assay. Mutat. Res. 2008, 651:40-45.
44. Zeiger E., Anderson B., Haworth S., Lawlor T., Mortelmans K. Salmonella mutagenicity tests. 4. Results from the testing of 300 chemicals. Environ. Mol. Mutagen. 1988, 11(Suppl. 12):1-158.
45. Dunkel V.C., Zeiger E., Brusick D., McCoy E., McGregor D., Mortelmans K., Rosenkranz H.S., Simmon V.F. Reproducibility of microbial mutagenicity assays: I. Tests with Salmonella typhimurium and Escherichia coli using a standardized protocol. Environ. Mutagen. 1984, 6(Suppl. 2):1-251.
46. Lanigan R.S., Yamarik T.A. Final report on the safety assessment of EDTA, calcium disodium EDTA, diammonium EDTA, dipotassium EDTA, disodium EDTA, TEA-EDTA, tetrasodium EDTA, tripotassium EDTA, trisodium EDTA, HEDTA, and trisodium HEDTA-cosmetic ingredient review expert panel. Int. J. Toxicol. 2002, 21:95-142.
47. Muralidhara Narasimhamurthy K. Assessment of in vivo mutagenic potency of ethylenediaminetetraacetic acid in albino mice. Food Chem. Toxicol. 1991, 29:845-849.
48. SIDS Initial Assessment Report for SIAM 20 on Phthalic anhydride, UNEP Publications. , 2005 (accessed 12.10.15). http://www.chem.unep.ch/irptc/sids/OECDSIDS/85449.pdf.
49. Fujita H., Nakano M., Sasaki M. Mutagenicity test of food additives with Salmonella typhimurium TA97 and TA102. III. Kenkyu Nenpo-Tokyo-Toritsu Eisei Kenkynsho 1988, 39:343-350.
50. Shelby M.D., Witt K.L. Comparison of results from mouse bone marrow chromosome aberration and micronucleus tests. Environ. Mol. Mutagen. 1995, 25:302-313.
51. NTP, NTP website at . http://tools.niehs.nih.gov/cebs3/ui.
52. Amer S.M., Aly F.A. Genotoxic effect of 2,4-dichlorophenoxy acetic acid and its metabolite 2,4-dichlorophenol in mouse. Mutat. Res. 2001, 494:1-12.
53. Sasaki Y.F., Sekihashi K., Izumiyama F., Nishidate E., Saga A., Ishida K., Tsuda S. The comet assay with multiple mouse organs: comparison of comet assay results and carcinogenicity with 208 chemicals selected from the IARC monographs and U.S. NTP carcinogenicity database. Crit. Rev. Toxicol. 2000, 30:629-799.
54. Mientières S., Biola A., Pallardy M., Marzin D. Using CTLL-2 and CTLL-2 bcl2 cells to avoid interference by apoptosis in the in vitro micronucleus test. Environ. Mol. Mutagen. 2003, 41:14-27.
55. Glauert H.P., Kennan W.S., Sattler G.L., Pitot H.C. Assays to measure the induction of unscheduled DNA synthesis in cultured hepatocytes. Prog. Mutat. Res. 1985, 5:371-373.
56. Lee C.G., Webber T.D. The induction of gene mutations in the mouse lymphoma L5178Y TK+/- assay and the Chinese hamster V79HGPRT assay. Prog. Mutat. Res. 1985, 5:5457-5554.
57. Kuroda Y., Yokoiyama A., Kada T. Assays for the induction of mutations to 6-thioguanine resistance in Chinese hamster V79 cells in culture. Prog. Mutat. Res. 1985, 5:537-542.
58. de Araújo A.M., Alves G.R., Avanço G.T., Santos Parizi J.L., Nai G.A. Assessment of methyl methacrylate genotoxicity by the micronucleus test. Braz. Oral Res. (São Paulo) 2013, 27:31-36.
59. Le Curieux F., Marzin D., Erb F. Comparison of three short-term assays: results on seven chemicals, Potential contribution to the control of water genotoxicity. Mutat. Res. 1993, 319:223-236.
60. Krishna G., Nath J., Petersen M., Ong T. Cyclophosphamide-induced cytogenetic effects in mouse bone marrow and spleen cells in in vivo and in vivo/in vitro assays. Teratog. Carcinog. Mutagen. 1987, 7:183-195.
61. Krishna G., Theiss J.C. Concurrent analysis of cytogenetic damage in vivo: a multiple endpoint-multiple tissue approach. Environ. Mol. Mutagen. 1995, 25:314-320.
62. Mavournin K.H., Blakey D.H., Cimino M.C., Salamone M.F., Heddle J.A. The in vivo micronucleus assay in mammalian bone marrow and peripheral blood. A report of the U.S. Environmental Protection Agency Gene-Tox Program. Mutat. Res. 1990, 239:29-80.
63. Heddle M., Hite B., Kirkhart K., Mavournin J.T., MacGregor G.W., Newell M.F. The induction of micronuclei as a measure of genotoxicity, A report of the U. S. Environmental Protection Agency Gene-Tox Program. Mutat. Res. 1983, 123:61-118.
64. Machemer L., Lorke D. Method for testing mutagenic effects of chemicals on spermatogonia of the Chinese hamster: results obtained with cyclophosphamide, saccharin, and cyclamate. Arzneimittelforschung 1975, 25:1889-1896.
65. Emerit I., Levy A., Feingold J. Chromosome effect of cyclophosphamide in various strains of mice. Ann. Genet. 1976, 19:203-206.
66. Leonard A., Deknudt G. Comparison in vivo of the clastogenic properties of busulfan and cyclophosphamide. C. R. Seances Soc. Biol. Fil. 1983, 177:239-242.
67. Barbarasa C., Luca D., Postica F., Covic M. In vivo cytogenetic screening for determination of the mutagenic potential of cyclophosphamide. Morphol. Embryol. (Bucur) 1979, 25:369-372.
68. De Boeck M., van der Leede B.J., Van Goethem F., De Smedt A., Steemans M., Lampo A., Vanparys P. Flow cytometric analysis of micronucleated reticulocytes: time- and dose-dependent response of known mutagens in mice, using multiple blood sampling. Environ. Mol. Mutagen. 2005, 46:30-42.
69. Witt K.L., Livanos E., Kissling G.E., Torous D.K., Caspary W., Tice R.R., Recio L. Comparison of flow cytometry- and microscopy-based methods for measuring micronucleated reticulocyte frequencies in rodents treated with nongenotoxic and genotoxic chemicals. Mutat. Res. 2008, 649:101-113.
70. Bowen D.E., Whitwell J.H., Lillford L., Henderson D., Kidd D., McGarry S., Pearce G., Beevers C., Kirkland D.J. Evaluation of a multi-endpoint assay in rats, combining the bone-marrow micronucleus test, the Comet assay and the flow-cytometric peripheral blood micronucleus test. Mutat. Res. 2011, 722:7-19.
71. Lambert I.B., Singer T.M., Boucher S.E., Douglas G.R. Detailed review of transgenic rodent mutation assays. Mutat. Res. 2005, 590:1-280.
72. Anderson D., Dhawan A., Yu T.-W., Plewa M.J. An investigation of bone marrow and testicular cells in vivo using the comet assay. Mutat. Res. 1996, 370:159-174.
73. Matsushima T., Hayashi M., Matsuoka A., Ishidate M., Miura K.F., Shimizu H., Suzuki Y., Morimoto K., Ogura H., Mure K., Koshi K., Sofuni T. Validation of the in vitro micronucleus test in a Chinese hamster lung cell line (CHL/IU). Mutagenesis 1999, 14:569-580.
74. Garriott M.L., Phelps J.B., Hoffman W.P. A protocol for the in vitro micronucleus test. I. Contributions to the development of a protocol suitable for regulatory submissions from an examination of 16 chemicals with different mechanisms of action and different levels of activity. Mutat. Res. 2002, 517:123-134.
75. Kirkland D. Evaluation of different cytotoxic and cytostatic measures for the in vitro micronucleus test (MNVit): Summary of results in the collaborative trial. Mutat. Res. 2010, 702:139-147.
76. Ishidate M., Harnois M., Sofuni T. A comparative analysis of data on the clastogenicity of 951 chemical substances tested in mammalian cell cultures. Mutat. Res. 1988, 195:151-213.
77. Miller K. Clastogenic effects of bleomycin, cyclophosphamide, and ethyl methanesulfonate on resting and proliferating human B- and T-lymphocytes. Mutat. Res. 1991, 251:241-251.
78. IARC Monographs on the evaluation of the carcinogenic risk of chemicals to humans. Overall evaluations of carcinogenicity: An updating of IARC Monographs 1-42. Supplement 7. International Agency for Research on Cancer, Lyon, France, 1987.
79. McCann J., Choi E., Yamasaki E., Ames B.N. Detection of carcinogens as mutagens in the Salmonella/microsome test: assay of 300 chemicals. Proc. Natl. Acad. Sci. U. S. A. 1975, 72:5135-5139.
80. Simmon V.F. In vitro mutagenicity assays of chemical carcinogens and related compounds with Salmonella typhimurium. J. Natl. Cancer Inst. 1979, 62:893-900.
81. Zeiger B., Anderson S., Haworth T., Lawlor K. Salmonella mutagenicity tests: V. Results from the testing of 311 chemicals. Environ. Mol. Mutagen 1992, 19(21):2-141.
82. Soukup S.W., Au W. The effect of ethylnitrosourea on chromosome aberrations in vitro and in vivo. Humangenetik 1975, 29:319-328.
83. Delker D.A., Geter D.R., Kleinert K.M., Gollapudi B.B. Frequency and spectrum of lacI mutations in the liver of Big Blue mice following the administration of genotoxic carcinogens singly and in series. Int. J. Toxicol. 2008, 27:35-42.
84. Chen T., Harrington-Brock K., Moore M.M. Mutant frequency and mutational spectra in the Tk and Hprt genes of N-ethyl-N-nitrosourea-treated mouse lymphoma cells. Environ. Mol. Mutagen. 2002, 39:296-305.
85. Hsie D.A., Casciano D.B., Couch D.F., Krahn J.P., O'Neill B.L. The use of Chinese hamster ovary cells to quantify specific locus mutation and to determine mutagenicity of chemicals. A report of the Gene-Tox program. Mutat. Res. 1981, 86:193-214.
86. Mitchell D.A., Casciano M.L., Meltz D.E., Robinson R.H., San G.M., Williams E.S. Unscheduled DNA synthesis tests. A report of the U. S. environmental protection agency Gene-Tox program. Mutat. Res. 1983, 123:363-410.
87. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Some N-Nitroso Compounds. International Agency for Research on Cancer, Lyon, France, vol. 17, 1978.
88. Green M.H., Muriel W.J., Bridges B.A. Use of a simplified fluctuation test to detect low levels of mutagens. Mutat. Res. 1976, 38:33-42.
89. Brusick D.J., Simmon V.F., Rosenkranz H.S., Ray V.A., Stafford R.S. An evaluation of the E. coli WP2 and WP2uvrA reverse mutation assay. Mutat. Res. 1980, 76:169-190.
90. Frei J.V., Venitt S. Chromosome damage in the bone marrow of mice treated with the methylating agents methyl methanesulphonate and N-methyl-N-nitrosourea in the presence or absence of caffeine, and its relationship with thymoma induction. Mutat. Res. 1975, 30:89-95.
91. Jenssen D., Ramel C. Dose response at low doses of X-irradiation and MMS on the induction of micronuclei in mouse erythroblasts. Mutat. Res. 1976, 41:311-319.
92. Wakata A., Miyamae Y., Sato S., Suzuki T., Morita T., Asano N., Awogi T., Kondo K., Hayashi M. Evaluation of the rat micronucleus test with bone marrow and peripheral blood: summary of the 9th collaborative study by CSGMT/JEMS. MMS. Collaborative Study Group for the Micronucleus Test Environmental Mutagen Society of Japan. Mammalian Mutagenicity Study Group. Environ. Mol. Mutagen. 1998, 32:84-100.
93. Suzuki N., Ikeda K., Kobayashi Y., Terashima Y., Shimada T., Suzuki T., Hagiwara S., Hatakeyama K., Nagaoka J., Yoshida Y., Saito J., Tanaka M. Evaluation of liver and peripheral blood micronucleus assays with 9 chemicals using young rats. A study by the Collaborative Study Group for the Micronucleus Test (CSGMT)/Japanese Environmental Mutagen Society (JEMS)-Mammalian Mutagenicity Study Group (MMS). Mutat. Res. 2005, 583:133-145.
94. Madle S., Dean S.W., Andrae U., Brambilla G., Burlinson B., Doolittle D.J., Furihata C., Hertner T., McQueen C.A., Mori H. Recommendations for the performance of UDS tests in vitro and in vivo. Mutat. Res. 1984, 312:263-285.
95. Mirsalis J.C., Tyson C.K., Butterworth B.E. Detection of genotoxic carcinogens in the in vivo-in vitro hepatocyte DNA repair assay. Environ. Mutagen. 1982, 4:553-562.
96. Clive D., McCuen R., Spector J.F., Piper C., Mavournin K.H. Specific gene mutations in L5178Y cells in culture. A report of the U.S. Environment Protection Agency Gene-Tox program. Mutat. Res. 1983, 115:225-251.
97. Moore M.M., Harrington-Brock K., Doerr C.L., Dearfield K.L. Differential mutant quantitation at the mouse lymphoma tk and CHO hgprt loci. Mutagenesis 1989, 4:394-403.
98. Sobol Z., Engel M.E., Rubitski E., Ku W.W., Aubrecht J., Schiestl R.H. Genotoxicity profiles of common alkyl halides and esters with alkylating activity. Mutat. Res. 2007, 633:80-94.
99. Oberly T.J., MA, Rexroat B.J., Bewsey K.K., Richardson K.C.M., ichaelis An evaluation of the CHO/HGPRT mutation assay involving suspension cultures and soft agar cloning: Results for 33 chemicals. Environ. Mol. Mutagen. 1990, 16:260-271.
100. Bradley M.O., Bhuyan B., Francis M.C., Langenbach R., Peterson A., Huberman E. Mutagenesis by chemical agents in V79Chinese hamster cells: a review and analysis of the literature. A report of the Gene-Tox Program. Mutat. Res. 1981, 87:81-142.
101. Moore M.M., Parker L., Huston J., Harrington-Brock K., Dearfield K.L. Comparison of mutagenicity results for nine compounds evaluated at the hgprt locus in the standard and suspension CHO assays. Mutagenesis 1991, 6:77-85.
102. Selden J.R., Dolbeare F., Clair J.H., Miller J.E., McGettigan K., DiJohn J.A., Dysart G.R., DeLuca J.G. Validation of a flow cytometric in vitro DNA repair (UDS) assay in rat hepatocytes. Mutat. Res. 1994, 315:147-167.
103. Valentin-Severin I., Thybaud V., Le Bon A.M., Lhuguenot J.C., Chagnon M.C. The autoradiographic test for unscheduled DNA synthesis: a sensitive assay for the detection of DNA repair in the HepG2 cell line. Mutat. Res. 2004, 559:211-217.
104. Clapp N.K., Craig A.W., Toya R.E. Oncogenicity by methyl methanesulfonate in male RF mice. Science 1968, 161:913-914.
105. Ames B.N., Durston W.E., Yamasaki E., Lee F.D. Carcinogens are mutagens: a simple test system combining liver homogenates for activation and bacteria for detection. Proc. Natl. Acad. Sci. U S A. 1973, 70:2281-2285.
106. Sakai M., Yoshida D., Mizusaki S. Mutagenicity of polycyclic aromatic hydrocarbons and quinones on Salmonella typhimurium TA97. Mutat. Res. 1985, 156:61-67.
107. Crofton-Sleigh C., Doherty A., Ellard S., Parry E.M., Venitt S. Micronucleus assays using cytochalasin-blocked MCL-5 cells, a proprietary human cell line expressing five human cytochromes P-450 and microsomal epoxide hydrolase. Mutagenesis 1993, 8:363-372.
108. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Certain Polycyclic Aromatic Hydrocarbons and Heterocyclic Compounds. International Agency for Research on Cancer, Lyon, France, vol. 3, 1973.
109. Witt K.L., Knapton A., Wehr C.M., Hook G.J., Mirsalis J., Shelby M.D., MacGregor J.T. Micronucleated erythrocyte frequency in peripheral blood of B6C3F1 mice from short-term, prechronic, and chronic studies of the NTP Carcinogenesis Bioassay Program. Environ. Mol. Mutagen. 2000, 36:163-194.
110. Ito Y., Ueda N., Maeda S., Murao S., Sugiyama T., Lee H., Harvey R.G. Induction of chromosomal aberrations in rat bone marrow cells and mutations in Salmonella typhimurium by benz[a]anthracene derivatives. Mutat. Res. 1988, 206:55-63.
111. Wangenheim J., Bolcsfoldi G. Mouse lymphoma L5178Y thymidine kinase locus assay of 50 compounds. Mutagenesis 1988, 3:193-205.
112. Von Der Hude W., Kalweit S., Engelhardt G., McKiernan S., Kasper P., Slacik-Erben R., Miltenburger H.G., Honarvar N., Fahrig R., Gorlitz B., Albertini S., Kirchner S., Utesch D., Potter-Locher F., Stopper H., Madle S. In vitro micronucleus assay with Chinese hamster V79 cells - results of a collaborative study with in situ exposure to 26 chemical substances. Mutat. Res. 2000, 468:137-163.
113. Nesnow S., Argus M., Bergman H., Chu K., Frith C., Helmes T., McGaughy R., Ray V., Slaga T.J., Tennant R., Weisburger E. Chemical carcinogens. A review and analysis of the literature of selected chemicals and the establishment of the Gene-Tox Carcinogen Data Base. A report of the U.S. Environmental Protection Agency Gene-Tox Program. Mutat. Res. 1986, 185:1-195.
114. Ashby J., Lefevre P.A., Burlinson B., Penman M.G. An assessment of the in vivo rat hepatocyte DNA-repair assay. Mutat. Res. 1985, 156:1-18.
115. Holme J.A., Søderlund E.J. Species differences in the cytotoxic and genotoxic effects of 2-acetylaminofluorene and its primary metabolites 2-aminofluorene and N-hydroxy-2-acetylaminofluorene. Carcinogenesis 1985, 6:421-425.
116. Suzuki H., Takasawa H., Kobayashi K., Terashima Y., Shimada Y., Ogawa I., Tanaka J., Imamura T., Miyazaki A., Hayashi M. Evaluation of a liver micronucleus assay with 12 chemicals using young rats (II): a study by the Collaborative Study Group for the Micronucleus Test/Japanese Environmental Mutagen Society-Mammalian Mutagenicity Study Group. Mutagenesis 2009, 24:9-16.
117. Sawada S., Yamanaka T., Yamatsu K., Furihata C., Matsushima T. Chromosome aberrations, micronuclei and sister-chromatid exchanges (SCEs) in rat liver induced in vivo by hepatocarcinogens including heterocyclic amines. Mutat. Res. 1991, 251:59-69.
118. Sasaki Y.F., Nishidate E., Izumiyama F., Matsusaka N., Tsuda S. Simple detection of chemical mutagens by the alkaline single-cell gel electrophoresis (Comet) assay in multiple mouse organs (liver, lung, spleen, kidney and bone marrow). Mutat. Res. 1997, 391:215-231.
119. Nesslany F., Marzin D. A micromethod for the in vitro micronucleus assay. Mutagenesis 1999, 14:403-410.
120. Lefevre P.A., Ashby J. Activity of 2-acetylaminofluorene as a UDS inducing agent in B6C3F1 mouse hepatocytes in vitro. Cell Biol. Toxicol. 1990, 6:15-21.
121. Fassina G., Abbondandolo A., Mariani L., Taningher M., Parodi S. Mutagenicity in V79 cells does not correlate with carcinogenicity in small rodents for 12 aromatic amines. J. Toxicol. Environ. Health 1990, 29:109-130.
122. Bitsch A., Fecher J., Jost M., Klohn P.C., Neumann H.G. Genotoxic and chronic toxic effects in the carcinogenicity of aromatic amines; recent results. Cancer Res. 1997, 143:209-223.
123. Otteneder M., Lutz W.K. Correlation of DNA adduct levels with tumor incidence: carcinogenic potency of DNA adducts. Mutat. Res. 1999, 424:237-247.
124. Ames B.N., Kammen H.O., Yamasaki E. Hair dyes are mutagenic: identification of a variety of mutagenic ingredients. Proc. Natl. Acad. Sci. U.S.A. 1975, 72:2423-2427.
125. Shahin M.M., Chopy C., Lequesne N. Comparisons of mutation induction by six monocyclic aromatic amines in Salmonella typhimurium tester strains TA97, TA1537, and TA1538. Environ. Mutagen. 1985, 7:535-546.
126. Cunningham M.L., Matthews H.B. Evidence for an acetoxyarylamine as the ultimate mutagenic reactive intermediate of the carcinogenic aromatic amine 2,4-diaminotoluene. Mutat. Res. 1990, 242:101-110.
127. George E., Westmoreland C. Evaluation of the in vivo genotoxicity of the structural analogues 2,6-diaminotoluene and 2,4-diaminotoluene using the rat micronucleus test and rat liver UDS assay. Carcinogenesis 1991, 12:2233-2237.
128. Suter W., Ahiabor R., Blanco B., Locher F., Mantovani F., Robinson M., Sreenan G., Staedtler F., Swingler T., Vignutelli A., Perentes E. Evaluation of the in vivo genotoxic potential of three carcinogenic aromatic amines using the Big Blue transgenic mouse mutation assay. Environ. Mol. Mutagen. 1996, 28:354-362.
129. ™ Mouse can distinguish carcinogenic from non-carcinogenic analogues of diaminotoluenes and nitronaphthalenes. Mutat. Res. 2006, 608:88-96.
130. Sasaki Y.F., Fujikawa K., Ishida K., Kawamura N., Nishikawa Y., Ohta S., Satoh M., Madarame H., Ueno S., Susa N., Matsusaka N., Tsuda S. The alkaline single cell gel electrophoresis assay with mouse multiple organs: results with 30 aromatic amines evaluated by the IARC and U.S. NTP. Mutat. Res. 1999, 440:1-18.
131. Loveday K.S., Anderson B.E., Resnick M.A., Zeiger E. Chromosome aberration and sister chromatid exchange tests in Chinese hamster ovary cells in vitro. V: results with 46 chemicals. Environ. Mol. Mutagen. 1990, 16:272-303.
132. Armstrong M.J., Bean C.L., Galloway S.M. A quantitative assessment of the cytotoxicity associated with chromosomal aberration detection in Chinese hamster ovary cells. Mutat. Res. 1992, 265:45-60.
133. Séverin I., Jondeau A., Dhabi L., MC Chagnon, 2,4-diamintoluene (2,4-DAT)-induced DNA damage, DNA repair and micronucleus formation in the human hepatoma cell line HepG2. Toxicology 2005, 213:138-146.
134. Green M.H., Muriel W.J. Use of repair-deficient E. coli strains and liver microsomes to characterize mutagenesis by dimethylnitrosamine. Chem. Biol. Interact. 1975, 11:63-65.
135. Yahagi T., Nagao M., Seino Y., Matsushima T., Sugimura T. Mutagenicities of N-nitrosamines on Salmonella. Mutat. Res. 1977, 48:121-129.
136. Skopek T.R., Liber H.L., Kaden D.A., Thilly W.G. Relative sensitivities of forward and reverse mutation assays in Salmonella typhimurium. Proc. Natl. Acad. Sci. U S A. 1978, 75:4465-4469.
137. Takashima R., Takasawa H., Kawasako K., Ohyama W., Okada E., Narumi K., Fujiishi Y., Wako Y., Yasunaga K., Hattori A., Kawabata M., Nakadate K., Nakagawa M., Hamada S. Evaluation of a repeated dose liver micronucleus assay in rats treated with two genotoxic hepatocarcinogens, dimethylnitrosamine and 2-acetylaminofluorene: the possibility of integrating micronucleus tests with multiple tissues into a repeated dose general toxicity study. Mutat. Res. 2015, 780-781:18-24.
138. Loveday K.S., Lugo M.H., Resnick M.A., Anderson B.E., Zeiger E. Chromosome aberration and sister chromatid exchange tests in Chinese hamster ovary cells in vitro: II. Results with 20 chemicals. Environ. Mol. Mutagen. 1989, 13:60-94.
139. Kuroki T., Drevon C., Montesano R. Microsome-mediated mutagenesis in V79 Chinese hamster cells by various nitrosamines. Cancer Res. 1977, 37:1044-1050.
140. O'Neill J.P., Couch D.B., Machanoff R., San Sebastian J.R., Brimer P.A., Hsie A.W. A quantitative assay of mutation induction at the hypoxanthine-guanine phosphoribosyl transferase locus in Chinese hamster ovary cells (CHO/HGPRT system): utilization with a variety of mutagenic agents. Mutat. Res. 1977, 45:103-109.
141. Brams A., de Meester C. Mutagenic potency of heterocyclic amines towards Salmonella typhimurium; possible causes of variability in the results observed. Mutat. Res. 1992, 280:103-107.
142. Alldrick A.J., Rowland I.R. Activation of the food mutagens IQ and MeIQ by hepatic S9 fractions derived from various species. Mutat. Res. 1985, 144:59-62.
143. Holme J.A., Hongslo J.K., Søderlund E., Brunborg G., TC, hristensen J., Alexander E.D., ybing Comparative genotoxic effects of IQ and MeIQ in Salmonella typhimurium and cultured mammalian cells. Mutat. Res. 1987, 187:181-190.
144. Brunborg J.A., Holme J., Alexander G., Becher J.K. Genotoxic activity of the N-acetylated metabolites of the food mutagens 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) and 2-amino-3,4-dimethylimidazo[4,5-f]quinoline (MeIQ). Mutagenesis 1988, 3:303-309.
145. Carman R.J., Van Tassell R.L., Kingston D.G., Bashir M., Wilkins T.D. Conversion of IQ, a dietary pyrolysis carcinogen to a direct-acting mutagen by normal intestinal bacteria of humans. Mutat. Res. 1988, 206:335-342.
146. Hayashi S., Møller M.E., Thorgeirsson S.S. Genotoxicity of heterocyclic amines in the Salmonella/hepatocyte system. Jpn. J. Cancer Res. 1985, 76:835-845.
147. Ayrton A.D., Williams E.J., Rodrigues A.D., Ioannides C., Walker R. The food pyrolysis product IQ enhances its own activation. Mutagenesis 1989, 4:205-207.
148. Loprieno N., Boncristiani G., Loprieno G. An experimental approach to identifying the genotoxic risk from cooked meat mutagens. Food Chem. Toxicol. 1991, 29:377-386.
149. Smith C., Payne V., Doolittle D.J., Debnath A.K., Lawlor T., Hansch C. Mutagenic activity of a series of synthetic and naturally occurring heterocyclic amines in Salmonella. Mutat. Res. 1992, 279:61-73.
150. Davis C.D., Schut H.A., Adamson R.H., Thorgeirsson U.P., Thorgeirsson S.S., Snyderwine E.G. Mutagenic activation of IQ, PhIP and MeIQx by hepatic microsomes from rat, monkey and man: low mutagenic activation of MeIQx in cynomolgus monkeys in vitro reflects low DNA adduct levels in vivo. Carcinogenesis 1993, 14:61-65.
151. Sasaki Y.F., Saga A., Akasaka M., Nishidate E., Watanabe-Akanuma M., Ohta T., Matsusaka N., Tsuda S. In vivo genotoxicity of heterocyclic amines detected by a modified alkaline single cell gel electrophoresis assay in a multiple organ study in the mouse. Mutat. Res. 1997, 395:57-73.
152. Durling J.J., Abramsson-Zetterberg L. A comparison of genotoxicity between three common heterocyclic amines and acrylamide. Mutat. Res. 2005, 580:103-110.
153. Minkler J.L., Carrano A.V. In vivo cytogenetic effects of the cooked-food-related mutagens Trp-P-2 and IQ in mouse bone marrow. Mutat. Res. 1984, 140:49-53.
154. Knasmüller S., Schwab C.E., Land S.J., Wang C.Y., Sanyal R., Kundi M., Parzefall P., Darroudi F. Genotoxic effects of heterocyclic amines in human derived hepatoma (HepG2) cells. Mutagenesis 1999, 14:533-539.
155. Pfau W., Martin F.L., Cole K.J., Venitt S., Phillips D.H., Grover P.L., Marquardt H. Heterocyclic aromatic amines induce DNA strand breaks and cell transformation. Carcinogenesis 1999, 20:545-551.
156. Perez C., Lopez de Cerain A., Bello J. Induction of micronuclei in V79 cells after combined treatments with heterocyclic aromatic amines. Food Chem. Toxicol. 2002, 40:1463-1467.
157. Beamand J.A., Barton P.T., Tredger J.M., Price R.J., Lake B.G. Effect of some cooked food mutagens on unscheduled DNA synthesis in cultured precision-cut rat, mouse and human liver slices. Food Chem. Toxicol. 1998, 36:455-466.
158. Aeschbacher H.U., Ruch E. Effect of heterocyclic amines and beef extract on chromosome aberrations and sister chromatid exchanges in cultured human lymphocytes. Carcinogenesis 1989, 10:429-431.
159. Rodrigues A.S., Silva I.D., Caria M.H., Laires A., Chaveca T., Glatt H.R., Rueff J. Genotoxicity assessment of aromatic amines and amides in genetically engineered V79 cells. Mutat. Res. 1994, 341:93-100.
160. Miura K.F., Hatanaka M., Otsuka C., Satoh T., Takahashi H., Wakabayashi K., Nagao M., Ishidate M. 2-Amino-3-methylimidazo[4,5-f]quinoline (IQ), a carcinogenic pyrolysate, induces chromosomal aberrations in Chinese hamster lung fibroblasts in vitro. Mutagenesis 1993, 8:349-354.
161. Snyderwine E.G., Schut H.A.J., Adamson R.H., Thorgeirsson U.P., Thorgeirsson S.S. Metabolic activation and genotoxicity of heterocyclic arylamines. Cancer Res. 1992, 52:2099-2102.
162. Malfatti M.A., Buonarati M.H., Turteltaub K.W., Shen N.H., Felton J.S. The role of sulfation and/or acetylation in the metabolism of the cooked-food mutagen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine in Salmonella typhimurium and isolated rat hepatocytes. Chem. Res. Toxicol. 1994, 7:139-147.
163. Holme J.A., Wallin H., Brunborg G., Søderlund E.J., Hongslo J.K., Alexander J. Genotoxicity of the food mutagen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP): formation of 2-hydroxamino-PhIP, a directly acting genotoxic metabolite. Carcinogenesis 1989, 10:1389-1396.
164. Buonarati M.H., Felton J.S. Activation of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) to mutagenic metabolites. Carcinogenesis 1990, 11:1133-1138.
165. Kaderlik K.R., Mulder G.J., Shaddock J.G., Casciano D.A., Teitel C.H., Kadlubar F.F. Effect of glutathione depletion and inhibition of glucuronidation and sulfation on 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) metabolism, PhIP-DNA adduct formation and unscheduled DNA synthesis in primary rat hepatocytes. Carcinogenesis 1994, 15:1711-1716.
166. Lynch A.M., Gooderham N.J., Davies D.S., Boobis A.R. Genetic analysis of PHIP intestinal mutations in MutaMouse. Mutagenesis 1998, 13:601-605.
167. Yu M., Jones M.L., Gong M., Sinha R., Schut H.A., Snyderwine E.G. Mutagenicity of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in the mammary gland of Big Blue rats on high-and low-fat diets. Carcinogenesis 2002, 23:877-884.
168. Tucker J.D., Carrano A.V., Allen N.A., Christenesen M.L., Knize M.G., Strout C.L., Felton J.S. In vivo cytogenetic effects of cooked food mutagens. Mutat. Res. 1989, 224:105-113.
169. Buonarati M.H., Tucker J.D., Minkler J.L., Wu R.W., Thompson L.H., Felton J.S. Metabolic activation and cytogenetic effects of 2-amino-1-methyl-6-phenylimidazo[4,5-b] pyridine (PhIP) in Chinese hamster ovary cells expressing murine cytochrome P450 IA2. Mutagenesis 1991, 6:253-259.
170. Otsuka C., Miura K.F., Satoh T., Hatanaka M., Wakabayashi K., Ishidate M. Cytogenetic effects of a food mutagen, 2-amino-1-methyl-6-phenylimidazo[4,5-beta]pyridine (PhIP), and its metabolite, 2-hydroxyamino-1-methy-6-phenylimidazo[4,5-beta]pyridine (N-OH-PhIP), on human and Chinese hamster cells in vitro. Mutat. Res. 1996, 367:115-121.
171. Yadollahi-Farsani M., Gooderham N.J., Davies D.S., Boobis A.R. Mutational spectra of the dietary carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) at the Chinese hamster hprt locus. Carcinogenesis 1996, 17:617-624.
172. Madle S., Korte A., Beek B. Species differences in mutagenicity testing: I. Micronucleus and SCE tests in rats, mice and Chinese hamsters with Aflatoxin B1. Teratogen. Carcinogen. Mutagen. 1986, 6:1-13.
173. Fabry L., Roberfroid M. Mutagenicity of aflatoxin B1: observations in vivo and their relation to in vitro activation. Toxicol. Lett. 1981, 7:245-250.
174. Li S.Y., Lin J.K. Sequential monitoring of cytogenetic damage in rat lymphocytes following in vivo exposure to aflatoxin B1 and N-nitrosophenacetin. Mutat. Res. 1990, 242:219-224.
175. Anwar W.A., Khalil M.M., Wild C.P. Micronuclei, chromosomal aberrations and aflatoxin-albumin adducts in experimental animals after exposure to aflatoxin B1. Mutat. Res. 1994, 322:61-67.
176. Ito Y., Nakamura Y., Nakamura Y. Suppression of aflatoxin B1- or methyl methanesulfonate-induced chromosome aberrations in rat bone marrow cells after treatment with S-methyl methanethiosulfonate. Mutat. Res. 1997, 393:307-316.
177. Watzl B., Neudecker C., Hänsch G.M., Rechkemmer G., Pool-Zobel B.L. Short-term moderate aflatoxin B1 exposure has only minor effects on the gut-associated lymphoid tissue of Brown Norway rats. Toxicology 1999, 5:93-102.
178. El-Zawahri M.M., Morad M.M., Khishin A.F. Mutagenic effect of aflatoxin G1 in comparison with B1. J. Environ. Pathol. Toxicol. Oncol. 1990, 10:45-51.
179. Rogers C.G., Boyes B.G., Lok E. Comparative genotoxicity of 3 procarcinogens in V79 cells as related to glutathione S-transferase activity of hepatocytes from untreated rats and those fed 2% butylated hydroxyanisole. Mutat. Res. 1990, 244:163-171.
180. Martin C.N., McDermid A.C., Garner R.C. Testing of known carcinogens and noncarcinogens for their ability to induce unscheduled DNA synthesis in HeLa cells. Cancer Res. 1978, 38:2621-2627.
181. NTP Comparative toxicity studies of o-, m-, and p-choroaniline and B6C3F1 mice. NTP Toxicity Report Series 1998, 43:79.
182. Beratergremium für umweltrelevante Altstoffe (BUA), vol 153, 164 pp. P-chloroaniline. December 1993.
183. Caspary W.J., Spencer Daston D., Myhr B.C., Mitchell A.D., Rudd C.J., Lee P.S. Evaluation of the L5178Y mouse lymphoma cell mutagenesis assay: interlaboratory reproducibility and assessment. Environ. Mol. Mutagen 1988, 12(Suppl. 13):195-229.
184. Hannan M.A., al-Dakan A.A., Hussain S.S., Amer M.H. Mutagenicity of cisplatin and carboplatin used alone and in combination with four other anticancer drugs. Toxicology 1989, 55:183-191.
185. Vancurová M., Procházková J., Srb V. Monitoring of effects of cis-diamminedichloroplatinum II (Platidiam). Part II. Tests for mutagenic activity in the indicator system of Salmonella typhimurium his-strains (Ames test). Neoplasma 1985, 32(3):307-312.
186. Sakamoto Y., Fujikawa K., Nagayabu O., Yamamoto K.S., Samejima K. Triple short-term tests with bacteria and Drosophila for assessment of mutagenicity of antineoplastics. Takeda Kenkyushoho 1985, 44:96-116.
187. Uno Y., Morita M. Mutagenic activity of some platinum and palladium complexes. Mutat. Res. 1993, 298:269-275.
188. Khynriam D., Prasad S.B. Cisplatin-induced genotoxic effects and endogenous glutathione levels in mice bearing ascites Dalton's lymphoma. Mutat. Res. 2003, 526:9-18.
189. Nersesyan A., Perrone E., Roggieri P., Bolognesi C. Genotoxic action of cycloplatam, a new platinum antitumor drug, on mammalian cells in vivo and in vitro. Chemotherapy 2003, 49:132-137.
190. Oliveira R.J., Baise E., Mauro Mde O., Pesarini J.R., Matuo R., Silva A.F., Ribeiro L.R., Mantovani M.S. Evaluation of chemopreventive activity of glutamine by the comet and the micronucleus assay in mice's peripheral blood. Environ. Toxicol. Pharmacol. 2009, 28:120-124.
191. Louro H., Silva M.J., Boavida M.G. Mutagenic activity of cisplatin in the lacZ plasmid-based transgenic mouse model. Environ. Mol. Mutagen. 2002, 40:283-291.
192. Krishnaswamy G., Dewey W.C. Cisplatin induced cell killing and chromosomal aberrations in CHO cells: treated during G1 or S phase. Mutat. Res. 1993, 293:161-172.
193. Vernole P., Pepponi R., D'Atri S. Role of mismatch repair in the induction of chromosomal aberrations and sister chromatid exchanges in cells treated with different chemotherapeutic agents. Cancer Chemother. Pharmacol. 2003, 52:185-192.
194. Nishi Y., Hasegawa M.M., Taketomi M., Ohkawa Y., Inui N. Comparison of 6-thioguanine-resistant mutation and sister chromatid exchanges in Chinese hamster V79 cells with forty chemical and physical agents. Cancer Res. 1984, 44:3270-3279.
195. Plooy A.C., van Dijk M., Berends F., Lohman P.H. Influence of treatment temperature on the genotoxic effects of cisplatin in CHO cells: cytotoxicity, mutagenicity and induction of lesions in DNA. Mutat. Res. 1985, 151:129-136.
196. Chibber R., Ord M.J. The mutagenic and carcinogenic properties of three second generation antitumour platinum compounds: a comparison with cisplatin. Eur. J. Cancer Clin. Oncol. 1989, 25:27-33.
197. Silva M.J., Costa P., Dias A., Valente M., Louro H., Boavida M.G. Comparative analysis of the mutagenic activity of oxaliplatin and cisplatin in the Hprt gene of CHO cells. Environ. Mol. Mutagen. 2005, 46:104-115.
198. Deng D.J., Müller K., Kasper P., Müller L. Effect of diallyl trisulfide on induction of UDS by mutagenic drugs in primary rat hepatocytes. Biomed. Environ. Sci. 1994, 7:85-90.
199. Gupta R.S., Bromke A., Bryant D.W., Gupta R., Singh B., McCalla D.R. Etoposide (VP16) and teniposide (VM26): novel anticancer drugs, strongly mutagenic in mammalian but not prokaryotic test systems. Mutagenesis 1987, 2:179-186.
200. Ashby J., Tinwell H., Glover P., Poorman-Allen P., Krehl R., Callander R.D., Clive D. Potent clastogenicity of the human carcinogen etoposide to the mouse bone marrow and mouse lymphoma L5178Y cells: comparison to Salmonella responses. Environ. Mol. Mutagen. 1994, 24:51-60.
201. IARC Monographs on the evaluation of the carcinogenic risk of chemicals to humans. Some Antiviral and Antineoplastic Drugs, and Other Pharmaceutical Agents. International Agency for Research on Cancer, Lyon, France, vol. 76, 2000.
202. Nakanomyo H., Hiraoka M., Shiraya M. Mutagenicity tests of etoposide and teniposide. J. Toxicol. Sci. 1986, 11(Suppl. 1):301-310.
203. Choudhury R.C., Palo A.K., Sahu P. Cytogenetic risk assessment of etoposide from mouse bone marrow. J. Appl. Toxicol. 2004, 24:115-122.
204. Galloway S.M., Miller J.E., Armstrong M.J., Bean C.L., Skopek T.R., Nichols W.W. DNA synthesis inhibition as an indirect mechanism of chromosome aberrations: comparison of DNA-reactive and non-DNA-reactive clastogens. Mutat. Res. 1998, 400:169-186.
205. Wang L., Roy S.K., Eastmond D.A. Differential cell cycle-specificity for chromosomal damage induced by merbarone and etoposide in V79 cells. Mutat. Res. 2007, 616:70-82.
206. Boos G., Stopper H. Genotoxicity of several clinically used topoisomerase II inhibitors. Toxicol. Lett. 2000, 116:7-16.
207. Le Fevre A.C., Boitier E., Marchandeau J.P., AS, arasin V.T., hybaud Characterization of DNA reactive and non-DNA reactive anticancer drugs by gene expression profiling. Mutat. Res. 2007, 619:16-29.
208. Hashimoto H., Satadal C., Berger N.A. Mutagenic activity of topoisomerase I inhibitors. Clin. Cancer Res. 1995, 1:369-376.
209. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. A Review of Human Carcinogens. A. Pharmaceuticals. International Agency for Research on Cancer, Lyon, France, 100A (2012), 448 pages.
210. Gatehouse D. Detection of mutagenic derivatives of cyclophosphamide and a variety of other mutagens in a microtitre fluctuation test, without microsomal activation. Mutat. Res. 1978, 53:289-296.
211. Wilcox A., Naidoo D.J., Wedd D.G.G. Comparison of Salmonella typhimurium TA102 with E. coli WP2 tester strains. Mutagenesis 1990, 5:285-292.
212. Hirai O., Miyamae Y., Hattori Y., Akashima M.T., Miyamoto A., Zaizen K., Mine Y. Microbial mutagenicity and in vitro chromosome aberration induction by FK973, a new antitumor agent. Mutat. Res. 1994, 324:43-50.
213. Rydén E., Ekström C., Hellmér L., Bolcsfoldi G. Comparison of the sensitivities of Salmonella typhimurium strains TA102 and TA2638A to 16 mutagens. Mutagenesis 2000, 15:495-502.
214. Sen S., Mukherjee A., Agarwal K., Sharma A. Phenethyl isothiocyanate modulates clastogenicity of mitomycin C and cyclophosphamide in vivo. Mutat. Res. 1996, 371:159-164.
215. Mukhopadhyay M.J., Saha A., Mukherjee A. Studies on the anticlastogenic effect of turmeric and curcumin on cyclophosphamide and mitomycin C in vivo. Food Chem. Toxicol. 1998, 36:73-76.
216. Miller B.M., Zitzelsberger H.F., Weier H.U., Adler I.D. Classification of micronuclei in murine erythrocytes: immunofluorescent staining using CREST antibodies compared to in situ hybridization with biotinylated gamma satellite DNA. Mutagenesis 1991, 6:297-302.
217. Suzuki T., Hayashi M., Sofuni T. Initial experiences and future directions for transgenic mouse mutation assays. Mutat. Res. 1994, 307:489-494.
218. Okada N., Masumura K., Nohmi T., Yajima N. Efficient detection of deletions induced by a single treatment of mitomycin C in transgenic mouse gpt delta using the Spi- selection. Environ. Mol. Mutagen. 1999, 34:106-111.
219. Chanda S., Erexson G., Riach C., Innes D., Stevenson F., Murli H., Bley K. Genotoxicity studies with pure trans-capsaicin. Mutat. Res. 2004, 557:85-97.
220. Lorge E., Thybaud V., Aardema M.J., Oliver J., Wakata A., Lorenzon G., Marzin D. SFTG international collaborative study on in vitro micronucleus test I. General conditions and overall conclusions of the study. Mutat. Res. 2006, 607:13-36.
221. Fellows M.D., O'Donovan M.R. Cytotoxicity in cultured mammalian cells is a function of the method used to estimate it. Mutagenesis 2007, 22:275-280.
222. Oberly T.J., Michaelis K.C., Rexroat M.A., Bewsey B.J., Garriott M.L. A comparison of the CHO/HGPRT+ and the L5178Y/TK+/- mutation assays using suspension treatment and soft agar cloning: results for 10 chemicals. Cell Biol. Toxicol. 1993, 9:243-257.
223. Davies M.J., Phillips B.J., Rumsby P.C. Molecular analysis of chemically-induced mutations in mammalian cell assays. Toxicol. In Vitro 1995, 9:513-518.
224. Wang J., Sawyer J.R., Chen L., Chen T., Honma M., Mei N., Moore M.M. The mouse lymphoma assay detects recombination, deletion, and aneuploidy, Toxicol. Sci. 2009, 109:96-105.
225. Rinkus S.J., Legator M.S. Chemical characterization of 465 known or suspected carcinogens and their correlation with mutagenic activity in the Salmonella typhimurium system. Cancer Res. 1979, 39:3289-3318.
226. O'Donovan M.R. The comparative responses of Salmonella typhimurium TA1537 and TA97a to a range of reference mutagens and novel compounds. Mutagenesis 1990, 5:267-274.
227. Diehl M., Fort F. Spiral Salmonella assay: validation against the standard pour-plate assay. Environ. Mol. Mutagen. 1996, 27:227-236.
228. McFee A.F. Genotoxic potency of three quinoline compounds evaluated in vivo in mouse marrow cells. Environ. Mol. Mutagen. 1989, 13:325-331.
229. McFee A.F., Tice R.R. Influence of treatment to sacrifice time and the presence of BrdUrd on chemically-induced aberration rates in mouse marrow cells. Mutat. Res. 1990, 241:95-108.
230. Trzos R.J., Petzold G.L., Brunden M.N., Swenberg J.A. The evaluation of sixteen carcinogens in the rat using the micronucleus test. Mutat. Res. 1978, 58:79-86.
231. Sato S., Takizawa H., Inui N. A comparison of micronucleus induction in 3 mouse strains with representative clastogens. Toxicol. Lett. 1990, 52:215-220.
232. Suzuki T., Itoh S., Nakajima M., Hachiya N., Hara T. Target organ and time-course in the mutagenicity of five carcinogens in MutaMouse: a summary report of the second collaborative study of the transgenic mouse mutation assay by JEMS/MMS. Mutat. Res. 1999, 444:259-268.
233. Horibata K., Ukai A., Kimoto T., Suzuki T., Kamoshita N., Masumura K., Nohmi T., Honma M. Evaluation of in vivo genotoxicity induced by N-ethyl-N-nitrosourea, benzo[a]pyrene, and 4-nitroquinoline-1-oxide in the Pig-a and gpt assays. Environ. Mol. Mutagen. 2013, 54:747-754.
234. Scolastici C., Alves de Lima R.O., Barbisan L.F., Ferreira A.L., Ribeiro D.A., Salvadori D.M. Lycopene activity against chemically induced DNA damage in Chinese hamster ovary cells. Toxicol. In Vitro 2007, 21:840-845.
235. Myhr B.C., Caspary W.J. Evaluation of the L5178Y mouse lymphoma cell mutagenesis assay: intralaboratory results for sixty-three coded chemicals tested at Litton Bionetics, Inc. Environ. Mol. Mutagen 1988, 12(Suppl. 13):103-194.
236. Hömme M., Jacobi H., Juhl-Strauss U., Witte I. Synergistic DNA damaging effects of 4-nitroquinoline-1-oxide and non-effective concentrations of methyl methanesulfonate in human fibroblasts. Mutat. Res. 2000, 461:211-219.
237. Kitano M., Hatano H., Shisa H. Strain difference of susceptibility to 4-nitroquinoline 1-oxide-induced tongue carcinoma in rats. Jpn. J. Cancer Res. 1992, 83:843-850.
238. Mandel R., Ryser H. Mutagenicity of cadmium in Salmonella typhimurium and its synergism with two nitrosamines. Mutat. Res. 1984, 138:9-16.
239. Seo K.S., Lee C.S. Mutagenicity of metal compounds using E. coli WP2uvrA. Misaengmul Hakhoechi 1993, 31:527-531.
240. Brams A., Buchet J.P., Cruyzen-Fayt M.C., De Meester C., Lauwerys R., Leonard A. A comparative study, with 40 chemicals, of the efficiency of the Salmonella assay and the SOS Chromotest (kit procedure). Toxicol. Lett. 1987, 38:123-133.
241. Pesheva M.S., Chankova S.G., Avramova T.V., Milanov D.V., Genova G.K. Studies on genotoxic effects of cadmium chloride in various test systems. Russ. J. Genet. 1997, 33:134-138.
242. Mukherjee A., Giri A.K., Sharma A., Talukder G. Relative efficacy of short-term tests in detecting genotoxic effects of cadmium chloride in mice in vivo. Mutat. Res. 1988, 206:285-295.
243. Fahmy M.A., Aly F.A. In vivo and in vitro studies on the genotoxicity of cadmium chloride in mice. J. Appl. Toxicol. 2000, 20:231-238.
244. Celik A., Büyükakilli B., Cimen B., Taşdelen B., Oztürk M.I., Eke D. Assessment of cadmium genotoxicity in peripheral blood and bone marrow tissues of male Wistar rats. Toxicol. Mech. Methods 2009, 19:135-140.
245. Seelbach A., Fissler B., Madle S. Further evaluation of a modified micronucleus assay with V79 cells for detection of aneugenic effects. Mutat. Res. 1993, 303:163-169.
246. Migliore L., Cocchi L., Nesti C., Sabbioni E. Micronuclei assay and FISH analysis in human lymphocytes treated with six metal salts. Environ. Mol. Mutagen. 1999, 34:279-284.
247. Cea G.C., Alarcon M.A., Th G. Weigert, Induction of chromosome aberration and sister-chromatid exchange (SCE) in human lymphocytes by cadmium chloride. IRCS J. Med. Sci. 1983, 11:997-998.
248. Helleday T., Nilsson R., Jenssen D. Arsenic [III] and heavy metal ions induce intrachromosomal homologous recombination in the hprt gene of V79 Chinese hamster cells. Environ. Mol. Mutagen. 2000, 35:114-122.
249. Zhou J., Lian X., Zheng S., Du J., Yang S. DNA lesion and hprt mutant frequency in rat lymphocytes and V79Chinese hamster lung cells exposed to cadmium. J. Occup. Health 2006, 48:93-99.
250. Schisler M.R., Gollapudi B.B., Moore M.M. Evaluation of the mouse lymphoma mutation assay (MLA) data of the U. S. National Toxicology Program (NTP) using International Workshop on Genotoxicity Tests (IWGT) criteria, Environmental Mutagen Society 41st Annual Meeting Abstracts. Environ. Mol. Mutagen. 2010, 51:732.
251. Igarashi M., Setoguchi M., Takada S., Itoh S., Furuhama K. Optimum conditions for detecting hepatic micronuclei caused by numerical chromosome aberration inducers in mice. Mutat. Res. 2007, 632:89-98.
252. Miller B., Pötter-Locher F., Seelbach A., Stopper H., Utesch D., Madle S. Evaluation of the in vitro micronucleus test as an alternative to the in vitro chromosomal aberration assay: position of the GUM Working Group on the in vitro micronucleus test. Mutat. Res. 1998, 410:81-116.
253. Galloway S.M., Armstrong M.J., Reuben C., Colman S., Brown B., Cannon C., Bloom A.D., Nakamura F., Ahmed M., Duk S., Rimpo J., Margolin B.H., Resnick M.A., Anderson B., Zeiger E. Chromosome aberrations and sister chromatid exchanges in Chinese hamster ovary cells: evaluations of 108 chemicals. Environ. Mol. Mutagen. 1987, 10(10):1-175.
254. Honma M., Zhang L.Z., Sakamoto H., Ozaki M., Takeshita K., Momose M., Hayashi M., Sofuni T. The need for long-term treatment in the mouse lymphoma assay. Mutagenesis 1999, 14:23-29.
255. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Re-evaluation of Some Organic Chemicals, Hydrazine and Hydrogen Peroxide. International Agency for Research on Cancer, Lyon, France, vol. 71, 1999.
256. Adler I.D., Kliesch U. Comparison of single and multiple treatment regimens in the mouse bone marrow micronucleus assay for hydroquinone (HQ) and cyclophosphamide (CP). Mutat. Res. 1990, 234:115-123.
257. Ciranni R., Barale R., Ghelardini G., Loprieno N. Benzene and the genotoxicity of its metabolites. II. The effect of the route of administration on the micronuclei and bone marrow depression in mouse bone marrow cells. Mutat. Res. 1988, 209:23-28.
258. Matsumoto M., Masumori S., Hirata-Koizumi M., Ono A., Honma M., Yokoyama K., Hirose A. Evaluation of in vivo mutagenicity of hydroquinone in Muta™ Mice. Mutat. Res. 2014, 775-776:94-98.
259. Ma H., Wang Z., Liao M. Genetic toxicity of taxol. Zhongguo Yaolixue Yu Dulixue Zazhi 1996, 10:173-177.
260. Tinwell H., Ashby J. Genetic toxicity and potential carcinogenicity of taxol. Carcinogenesis 1994, 15:1499-1501.
261. Mughal A., Vikram A., Ramarao P., Jena G.B. Micronucleus and comet assay in the peripheral blood of juvenile rat: establishment of assay feasibility, time of sampling and the induction of DNA damage. Mutat. Res. 2010, 700:86-94.
262. Digue L., Orsière T., De Méo M., Mattéi M.G., Depetris D., Duffaud R., Favre A., Botta Evaluation of the genotoxic activity of paclitaxel by the in vitro micronucleus test in combination with fluorescent in situ hybridization of a DNA centromeric probe and the alkaline single cell gel electrophoresis technique (comet assay) in human T-lymphocytes. Environ. Mol. Mutagen. 1999, 34:269-278.
263. Steiblen G., Orsière T., Pallen C., Botta A., Marzin D. Comparison of the relative sensitivity of human lymphocytes and mouse splenocytes to two spindle poisons. Mutat. Res. 2005, 588:143-151.
264. Hashimoto K., Nakajima Y., Matsumura S., Chatani F. An in vitro micronucleus assay with size-classified micronucleus counting to discriminate aneugens from clastogens. Toxicol. In Vitro 2010, 24:208-216.
265. Mühlbauer P.A., Schuler M.J. Detection of numerical chromosomal aberrations by flow cytometry: a novel process for identifying aneugenic agents. Mutat. Res. 2005, 585:156-169.
266. Bakshi N., Neita M., Dutta S.K. Genotoxic activity of antitumor drugs: A comparison of Ames reverse mutation assay with E. coli DNA repair assay. Nucleus (Calcutta) 1985, 28:159-168.
267. Vanparys P., Vermeiren F., Sysmans M., Temmerman R. The micronucleus assay as a test for the detection of aneugenic activity. Mutat. Res. 1990, 244:95-103.
268. Grawé J., Nüsse M., Adler I.D. Quantitative and qualitative studies of micronucleus induction in mouse erythrocytes using flow cytometry. I. Measurement of micronucleus induction in peripheral blood polychromatic erythrocytes by chemicals with known and suspected genotoxicity. Mutagenesis 1997, 12:1-8.
269. Choudhury R.C., Palo A.K., Padhy A. Cytogenetic consequences of vinblastine treatment in mouse bone marrow. Chemotherapy 2004, 50:171-177.
270. Fiedler R.D., Weiner S.K., Schuler M. Evaluation of a modified CD71 MicroFlow method for the flow cytometric analysis of micronuclei in rat bone marrow erythrocytes. Mutat. Res. 2010, 703:122-129.
271. Coffing S., Engel M., Dickinson D., Thiffeault C., Spellman R., Shutsky T., Schuler M. The rat gut micronucleus assay: a good choice for alternative in vivo genetic toxicology testing strategies. Environ. Mol. Mutagen. 2011, 52:269-279.
272. Eastmond D.A., Tucker J.D. Kinetochore localization in micronucleated cytokinesis-blocked Chinese hamster ovary cells: a new and rapid assay for identifying aneuploidy-inducing agents. Mutat. Res. 1989, 224:517-525.
273. Darroudi F., Meijers C.M., Hadjidekova V., Natarajan A.T. Detection of aneugenic and clastogenic potential of X-rays, directly and indirectly acting chemicals in human hepatoma (Hep G2) and peripheral blood lymphocytes, using the micronucleus assay and fluorescent in situ hybridization with a DNA centromeric probe. Mutagenesis 1996, 11:425-433.
274. Z.Sobol M.L., Homiski D.A., Dickinson R.A., Spellman D., Li A., Scott J.R., Cheung S.L., Coffing J.B., Munzner K.E., Sanok W.C., Gunther K.L., Dobo M.Schuler Development and validation of an in vitro micronucleus assay platform in TK6 cells. Mutat. Res. 2012, 746:29-34.
275. Honma M., Momose M., Sakamoto H., Sofuni T., Hayashi M. Spindle poisons induce allelic loss in mouse lymphoma cells through mitotic non-disjunction. Mutat. Res. 2001, 493:101-114.
276. Ayers K.M., Clive D., Tucker W.E., Hajian G., de Miranda P. Nonclinical toxicology studies with zidovudine: genetic toxicity tests and carcinogenicity bioassays in mice and rats. Fund. Appl. Toxicol. 1996, 32:148-158.
277. Phillips M.D., Nascimbeni B., Tice R.R., Shelby M.D. Induction of micronuclei in mouse bone marrow cells: an evaluation of nucleoside analogues used in the treatment of AIDS. Environ. Mol. Mutagen. 1991, 18:168-183.
278. Torres S.M., Walker D.M., Carter M.M., Cook D.L., McCash C.L., Cordova E.M., Olivero O.A., Poirier M.C., Walker V.E. Mutagenicity of zidovudine, lamivudine, and abacavir following in vitro exposure of human lymphoblastoid cells or in utero exposure of CD-1 mice to single agents or drug combinations. Environ. Mol. Mutagen. 2007, 48:224-238.
279. Meng Q., Su T., Olivero O.A., Poirier M.C., Shi X., Ding X., Walker V.E. Relationships between DNA incorporation, mutant frequency, and loss of heterozygosity at the TK locus in human lymphoblastoid cells exposed to 3'-azido-3'-deoxythymidine. Toxicol. Sci. 2000, 54:322-329.
280. Zeiger E., Anderson B., Haworth S., Lawlor T., Mortelmans K., Speck W. Salmonella mutagenicity tests: III. Results from testing of 255 chemicals. Environ. Mol. Mutagen. 1987, 9(Suppl. 9):1-110.
281. De Flora S., Camoirano A., Zanacchi P., Bennicelli C. Mutagenicity testing with TA97 and TA102 of 30 DNA-damaging compounds, negative with other Salmonella strains. Mutat. Res. 1984, 134:159-165.
282. Hayashi M., Sofuni T., Kodama Y., Ishidate M., Tamura H. Micronucleus test with 1-beta-d-arabinofuranosylcytosine administered by intraperitoneal injection and oral gavage. Mutat. Res. 1989, 223:345-348.
283. Higashikuni N., Sutou S. An optimal, generalized sampling time of 30±6h after double dosing in the mouse peripheral blood micronucleus test. Mutagenesis 1995, 10:313-319.
284. Moore R.C. Effects of 1-beta-d-arabinofuranosylcytosine on chromosomes, depending upon the cell cycle stage at the time of exposure. Mutat. Res. 1981, 83:361-374.
285. Pantelias G.E., Wolff S. Cytosine arabinoside is a potent clastogen and does not affect the repair of X-ray-induced chromosome fragments in unstimulated human lymphocytes. Mutat. Res. 1985, 151:65-72.
286. Sekizawa K., Suzuki T., Kishi K. Cytogenetic study of the induction mechanism of chromosome-type aberrations by 1-beta-D-arabinofuranosylcytosine. Mutat. Res. 2007, 619:1-8.
287. Watanabe K., Sasaki T., Kawakami K. Comparisons of chemically-induced mutation among four bacterial strains, Salmonella typhimurium TA102 and TA2638, and E. coli WP2/pKM101 and WP2uvrA/pKM101: collaborative study III and evaluation of the usefulness of these strains. Mutat. Res. 1998, 416:169-181.
288. Ohuchida A., Furukawa A., Yoshida J., Watanabe M., Aruga F., Miwa Y., Shinkawa K., Kinae N. Micronucleus assays on 5-fluorouracil and 6-mercaptopurine with mouse peripheral blood reticulocytes. Mutat. Res. 1992, 278:139-143.
289. Oka H., Ouchida M., Kondo T., Morita F., Shimizu K. Different responses to 5-fluorouracil in mutagenicity and gene expression between two human lymphoblastoid cell lines with or without TP53 mutation. Acta Med. Okayama 2012, 66:119-129.
290. Cavalieri A., Albert P.F., Vitali R. 5-Fluorouracil carcinogenesis in Balb/C mice. Tumori 1990, 76:179-181.
291. Iwagama M., Nakmura M., Izumi K., Otsuka H. Carcinogenicity testing of 5-fluorouracil in (C57BL/6 X C3H) F1 mice. J. Toxicol. Pathol. 1991, 4:129-135.
292. Toyoda K., Shibutani M., Sato H., Uneyama C., Takahashi M., Hayashi Y., Hirose M. Lack of carcinogenicity and increased survival in F344 rats treated with 5-fluorouracil for two years. Food Chem. Toxicol. 2000, 38:187-193.
293. Marzin D.R., Phi H.V. Study of the mutagenicity of metal derivatives with Salmonella typhimurium TA102. Mutat. Res. 1985, 155:49-51.
294. Tinwell H., Stephens S.C., Ashby J. Arsenite as the probable active species in the human carcinogenicity of arsenic: mouse micronucleus assays on Na and K arsenite, orpiment, and Fowler's solution. Environ. Health Perspect. 1991, 95:205-210.
295. Lewińska D., Arkusz J., Stańczyk M., Palus J., Dziubałtowska E., Stepnik M. Comparison of the effects of arsenic and cadmium on benzo(a) pyrene-induced micronuclei in mouse bone-marrow. Mutat. Res. 2007, 632:37-43.
296. Wan B., Christian R.T., Soukup S.W. Studies of cytogenetic effects of sodium arsenicals on mammalian cells in vitro. Environ. Mutagen. 1982, 4:493-498.
297. Huang R.N., Ho I.C., Yih L.H., Lee T.C. Sodium arsenite induces chromosome endoreduplication and inhibits protein phosphatase activity in human fibroblasts. Environ. Mol. Mutagen. 1995, 25:188-196.
298. Kochhar T.S., Howard W., Hoffman S., Brammer-Carleton L. Effect of trivalent and pentavalent arsenic in causing chromosome alterations in cultured Chinese hamster ovary (CHO) cells. Toxicol. Lett. 1996, 84:37-42.
299. Ramäirez P., Eastmond D.A., Laclette J.P., Ostrosky-Wegman P. Disruption of microtubule assembly and spindle formation as a mechanism for the induction of aneuploid cells by sodium arsenite and vanadium pentoxide. Mutat. Res. 1997, 386:291-298.
300. Chakraborty T., De M. Clastogenic effects of inorganic arsenic salts on human chromosomes in vitro. Drug Chem. Toxicol. 2009, 32:169-173.
301. Yih L.H., Lee T.C. Effects of exposure protocols on induction of kinetochore-plus and -minus micronuclei by arsenite in diploid human fibroblasts. Mutat. Res. 1999, 440:75-82.
302. Sinha D., Roy M., Siddiqi M., Bhattacharya R.K. Arsenic-induced micronuclei formation in mammalian cells and its counteraction by tea. J. Environ. Pathol. Toxicol. Oncol. 2005, 24:45-56.
303. Colognato R., Coppedè F., Ponti J., Sabbioni E., Migliore L. Genotoxicity induced by arsenic compounds in peripheral human lymphocytes analysed by cytokinesis-block micronucleus assay. Mutagenesis 2007, 22:255-261.
304. Moore M.M., Harrington-Brock K., Doerr C.L. Relative genotoxic potency of arsenic and its methylated metabolites. Mutat. Res. 1997, 386:279-290.
305. Soriano C., Creus A., Marcos R. Gene-mutation induction by arsenic compounds in the mouse lymphoma assay. Mutat. Res. 2007, 634:40-50.
306. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Arsenic, Metals, Fibres and Dusts. International Agency for Research on Cancer, Lyon, France, vol. 100C (2012).
307. Stemp G., Pascoe S., Gatehouse D. In vitro and in vivo cytogenetic studies of three ß-lactam antibiotics (penicillin VK, ampicillin and carbenicillin). Mutagenesis 1989, 4:439-445.
308. Jaju M., Jaju M., Ahuja Y.R. Evaluation of genotoxicity of ampicillin and carbenicillin on human lymphocytes in vitro: chromosome aberrations, mitotic index, cell cycle kinetics, satellite associations of acrocentric chromosomes and sister chromatid exchanges. Hum. Toxicol. 1984, 3:173-191.
309. Brambilla G., Martelli A. Update on genotoxicity and carcinogenicity testing of 472 marketed pharmaceuticals. Mutat. Res. 2009, 681:209-229.
310. Prival M.J., Simmon V.F., Mortelmans K.E. Bacterial mutagenicity testing of 49 food ingredients gives very few positive results. Mutat. Res. 1991, 260:321-329.
311. Summary of Toxicology data on chlormequat chloride. California EPA Department of Pesticide Regulation Medical Toxicology Branch. Toxicology Data Review Summaries. Original Document 12-24-2002. Information retrieved as of June 2015, at , (accessed 23.10.15). http://www.cdpr.ca.gov/docs/risk/toxsums/toxsumlist.htm.
312. Stoyanov I.S., Nicolov I.G., Chernozemsky I.N., Stoichev I. Assessment for mutagenicity of 10 pharmaceutical products following Ames, micronucleus, and sperm morphology testing. Toxic. Assess. 1987, 2:207-215.
313. Kuboyama M., Fujii A. Mutagenicity of analgesics, their derivatives, and anti-inflammatory drugs with S-9 mix of several animal species. J. Nihon Univ. Sch. Dent. 1992, 34:183-195.
314. Kadotani S., Arisawa M., Maruyama H.B. Mutagenicity examination of several non-steroidal anti-inflammatory drugs in bacterial systems. Mutat. Res. 1984, 138:133-136.
315. Snyder R.D., Green J.W. A review of the genotoxicity of marketed pharmaceuticals. Mutat. Res. 2001, 488:151-169.
316. FDA, . http://www.fda.gov/.
317. EPAR Zonegran, . http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_Scientific_Discussion/human/000577/WC500052398.pdf.
318. OECD SIDS. Initial Assessment Report For SIAM 6 on 1-chlorobuthane, UNEP Publications (1997) 1-41, (accessed 12.10.15). http://www.chem.unep.ch/irptc/sids/OECDSIDS/109693.pdf.
319. Anderson B.E., Zeiger E., Shelby M.D., Resnick M.A., Gulati D.K., Ivett J.L., Loveday K.S. Chromosome aberration and sister chromatid exchange test results with 42 chemicals. Environ. Mol. Mutagen. 1990, 16(Suppl. 18):55-137.
320. Dunkel V.C., Zeiger E., Brusick D., McCoy E., McGregor D., Mortelmans K., Rosenkranz H.S., Simmon V.F. Reproducibility of microbial mutagenicity assays: II. Testing of carcinogens and noncarcinogens in Salmonella typhimurium and E. coli. Environ. Mutagen. 1985, 7(Suppl. 5):1-248.
321. Hilliard C.A., Armstrong M.J., Bradt C.I., Hill R.B., Greenwood S.K., Galloway S.M. Chromosome aberrations in vitro related to cytotoxicity of nonmutagenic chemicals and metabolic poisons. Environ. Mol. Mutagen. 1998, 31:316-326.
322. Moriya M., Ohta T., Watanabe K., TM, iyazawa K., Kato Y.S., hirasu Further mutagenicity studies on pesticides in bacterial reversion assay systems. Mutat. Res. 1983, 116(3-4):185-216.
323. B. Wallner, Reverse Mutation Assay using bacteria (Salmonella typhymurium and E. coli) with amitrole technical BSL 2009 Bioservice No. 992153-EFSA DAR Report Vol. 3 Annex B, B.6. Toxicology and Metabolism January (2013).
324. Carver J.H., Bootman J., Cimino M.C., Esber H.J., Kirby P., Kirkhart B., AWong Z., MacGregor J.A. Genotoxic potential of acephate technical: in vitro and in vivo effects. Toxicology 1985, 35:125-142.
325. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Some Thyrotropic Agents. International Agency for Research on Cancer, Lyon, France, vol. 79 (2001).
326. Agarwal D.K., Lawrence W.H., Nunez L.J., Autian J. Mutagenicity evaluation of phthalic acid esters and metabolites in Salmonella typhimurium cultures. J. Toxicol. Environ. Health 1985, 16(1):61-69.
327. European Chemicals Bureau; European Union Risk Assessment Report, Bis(2-ethylhexyl) phthalate (DEHP) (117-81-7) , (accessed 12.10.15). http://echa.europa.eu/web/guest/information-on-chemicals/information-from-existing-substances-regulation.
328. Environmental Health Criteria: Diethylhexyl Phthalate by the International Programme on Chemical Safety (IPCS) under the joint sponsorship of the United Nations Environment Programme, the International Labour Organisation and the World Health Organization. No. 131 (1992) 13-18.
329. IARC Monographs on Some Chemicals Present in Industrial and Consumer Products, Food and Drinking-water. International Agency for Research on Cancer, Lyon, France, vol. 101 (2012).
330. Crebelli R., Carere A., Leopardi P., Conti L., Fassio F., Raiteri F., Barone D., Ciliutti P., Cinelli S., Vericat J.A. Evaluation of 10 aliphatic halogenated hydrocarbons in the mouse bone marrow micronucleus test. Mutagenesis 1999, 14:207-215.
331. Parry J.M., Parry E.M., Bourner R., Doherty A., Ellard S., O'Donovan J., Hoebee B., de Stoppelaar J.M., Mohn G.R., Önfelt A., Renglin A., Schultz N., Söderpalm-Berndes C., Jensen K.G., Kirsch-Volders M., Elhajouji A., Van Hummelen P., Degrassi F., Antoccia A., Cimini D., Izzo M., Tanzarella C., Adler I.-D., Kliesch U., Schriever-Schwemmer G., Gasser P., Crebelli R., Carere A., Andreoli C., Benigni R., Leopardi P., Marcon F., Zinjo Z., Natarajan A.T., Boei J.J.W.A., Kappas A., Voutsinas G., Zarani F.E., Patrinelli A., Pachierotti F., Tiveron C., Hess P. The detection and evaluation of aneugenic chemicals. Mutat. Res. 1996, 353:11-46.
332. Doherty A.T., Ellard S., EM, Parry J.M.P., arry An investigation into the activation and deactivation of chlorinated hydrocarbons to genotoxins in metabolically competent human cells. Mutagenesis 1996, 11(3):247-274.
333. Taningher M., Parodi S., Grilli S., Colacci A., Mazzullo M., Bordone R., Santi L. Lack of correlation between alkaline DNA fragmentation and DNA covalent binding induced by polychloroethanes after in vivo administration. Problems related to the assessment of a carcinogenic hazard. Cancer Detect. Prevent. 1991, 15:35-39.
334. Jung R., GE, ngelhardt B., Herbold R.J., ackh W.M., uller Collaborative study of mutagenicity with Salmonella typhimurium TA102. Mutat. Res. 1992, 278:265-270.
335. Nesslany F., Zennouche N., Simar-Meintières S., Talahari I., Nkili-Mboui E.N., Marzin D. In vivo Comet assay on isolated kidney cells to distinguish genotoxic carcinogens from epigenetic carcinogens or cytotoxic compounds. Mutat. Res. 2007, 630:28-41.
336. Haworth S., Lawlor T., Mortelmans K., Speck W. Salmonella mutagenicity tests for 250 chemicals. Environ. Mutagen. 1983, 5(Suppl. 1):3-142.
337. IUCLID International Uniform ChemicaL Information Database 5.6, maintained by the European Chemicals Agency, . http://iuclid.eu/index.php%3Ffuseaction=home.iuclidHome.
338. Mast R.W., Naismith R.W., Friedman M.A. Mouse micronucleus assay of melamine. Environ. Mutagen. 1982, 4:340-341. abstract.
339. Okumura M., Hasegawa R., Shirai T., Ito M., Yamada S., Fukushima S. Relationship between calculus formation and carcinogenesis in the urinary bladder of rats administered the non-genotoxic agents thymine or melamine. Carcinogenesis 1992, 13(6):1043-1045.
340. Shelby M.D., Tice R.R. Methyl carbamate: negative results in mouse bone-marrow micronucleus test. Mutat. Res. 1991, 260(4):311.
341. Aeschbacher H.U., Wolleb U., Löliger J., Spadone J.C., Liardon R. Contribution of coffee aroma constituents to the mutagenicity of coffee. Food Chem. Toxicol. 1989, 27:227-232.
342. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Some Industrial Chemicals. International Agency for Research on Cancer, Lyon, France, vol. 77 (2000).
343. MacGregor J.A., Hamilton C.M., Kubicek J., Mirsalis J.C. Pyridine does not induce unscheduled DNA synthesis (UDS) in hepatocytes of male B6C3F1 mice treated in vivo. J. Appl. Toxicol. 2000, 20:389-393.
344. European Food Safety Authority (EFSA) DAR Report on Pyriofenone Vol. 3 Annex B-6. Toxicol. Metabol., January (2012).
345. McGregor D.B., Cruzan G., Callander R.D., May K., Banton M. The mutagenicity testing of tertiary-butyl alcohol, tertiary-butyl acetate and methyl tertiary-butyl ether in Salmonella typhimurium. Mutat. Res. 2005, 565(2):181-189.
346. ECHA, Information from Registration Dossiers and Notifications to the C&L Inventory for CAS no. 78-42-2 (as retrieved as of June 2015). http://echa.europa.eu/web/guest/information-on-chemicals/registered-substances.
347. Gadupudi G.S., Chung K.T. Comparative genotoxicity of 3-hydroxyanthranilic acid and anthranilic acid in the presence of a metal cofactor Cu (II) in vitro. Mutat. Res. 2011, 726:200-208.
348. McFee A.F., Jauhar P.P., Lowe K.W., MacGregor J.T., Wehr C.M. Assays of three carcinogen/non-carcinogen chemical pairs for in vivo induction of chromosome aberrations, sister chromatid exchanges and micronuclei. Environ. Mol. Mutagen. 1989, 14:207-220.
349. Shelby M.D., Stasiewicz S. Chemicals showing no evidence of carcinogenicity in long-term, two-species rodent studies: the need for short-term test data. Environ. Mutagen. 1984, 6:871-878.
350. Oshiro Y., Piper C.E., Balwierz P.S., Soelter S.G. Chinese hamster ovary cell assays for mutation and chromosome damage: data from non-carcinogens. J. Appl. Toxicol. 1991, 11:167-177.
351. H. Fujita, C. Sumi, M. Sasaki, Mutagenicity test of food additives with Salmonella typhimurium TA97 and TA102, VII, Kenkyu Nenpo-Tokyo-Toritsu Eisei Kenkyusho 43 (1992) 219-227.
352. Hayashi M., Kishi M., Sofuni T., Ishidate M. Micronucleus tests in mice on 39 food additives and eight miscellaneous chemicals. Food Chem. Toxicol. 1988, 26:487-500.
353. Myhr B., McGregor D., Bowers L., Riach C., Brown A.G., Edwards I., McBride D., Martin R., Caspary W.J. L5178Y mouse lymphoma cell mutation assay results with 41 compounds. Environ. Mol. Mutagen 1990, 16(Suppl. 18):138-167.
354. McGregor D.B., Brown A.G., Howgate S., McBride D., Riach C., Caspary W.J. Responses of the L5178Y mouse Lymphoma cell forward mutation assay. V: 27 coded chemicals. Environ. Mol. Mutagen. 1991, 17:196-219.
355. Hakura A., Tsutsui Y., Mochida H., Sugihara Y., Mikami T., Sagami F. Mutagenicity of dihydroxybenzenes and dihydroxynaphthalenes for Ames Salmonella tester strains. Mutat. Res. 1996, 371:293-299.
356. JETOC-Japan Chemical Industry Ecology-Toxicology and Information Center, Japan, Mutagenicity test data of existing chemical substances based on the toxicity investigation of the Industrial Safety and health law, Suppl., 1997.
357. Natarajan A.T., Obe G. How do in vivo mammalian assays compare to in vitro assays in their ability to detect mutagens?. Mutat. Res. 1986, 167:189-201.
358. Darroudi F., Natarajan A.T. Cytogenetic analysis of human peripheral blood lymphocytes (in vitro) treated with resorcinol. Mutat. Res. 1983, 124:179-189.
359. JETOC-Japan Chemical Industry Ecology-Toxicology and Information Center, Japan, Mutagenicity test data of existing chemical substances based on the toxicity investigation of the Industrial Safety and health law, Suppl. 4, 2008.
360. Stenback F., Shubik P. Lack of toxicity and carcinogenicity of some commonly used cutaneous agents. Toxicol. Appl. Pharmacol. 1974, 30:7-13.
361. Harvey J.S., Howe J.R., Lynch A.M., Ress R.W. The results of five coded compounds: genistein, metaproterenol, rotenone, p-anisidine and resorcinol tested in the pH 6.7 Syrian hamster embryo cell morphological transformation assay. Mutagenesis 2005, 20:51-56.
362. Slesinski R.S., Guzzie P.J., Putman D.L., Ballantyne B. In vitro and in vivo evaluation of the genotoxic potential of 2-ethyl-1,3-hexanediol. Toxicology 1988, 53:179-198.
363. Ishidate M., Sofuni T., oshikawa K.Y., Hayashi M., Nohmi T., Sawada M., Matsuoka A. Primary mutagenicity screening of food additives currently used in Japan. Food Chem. Toxicol. 1984, 22:623-636.
364. Sekizawa J., Shibamoto T. Genotoxicity of safrole-related chemicals in microbial test systems. Mutat. Res. 1982, 101:127-140.
365. Woolverton C.J., Fotos P.G., Mokas M.J., Mermigas M.E. Evaluation of eugenol for mutagenicity by the mouse micronucleus test. J. Oral Pathol. 1986, 15:450-453.
366. Ellahueñe M.F., Pérez-Alzola L.P., Orellana-Valdebenito M., Muñoz C., Lafuente-Indo N. Genotoxic evaluation of eugenol using the bone marrow micronucleus assay. Mutat. Res. 1994, 320:175-180.
367. Shelby M.D., Erexson G.L., Hook G.J., Tice R.R. Evaluation of a three-exposure mouse bone marrow micronucleus protocol: results with 49 chemicals. Environ. Mol. Mutagen. 1993, 21:160-179.
368. Allavena A., Martelli A., Robbiano L., Brambilla G. Evaluation in a battery of in vivo assays of four in vitro genotoxins proved to be noncarcinogens in rodents. Teratogen. Carcinogen. Mutagen. 1992, 12:31-41.
369. Maura A., Pino A., Ricci R. Negative evidence in vivo of DNA-damaging, mutagenic and chromosomal effects of eugenol. Mutat. Res. 1989, 227:125-129.
370. Rompelberg C.J., Evertz S.J., Bruijntjes-Rozier G.C., van den Heuvel P.D., Verhagen H. Effect of eugenol on the genotoxicity of established mutagens in the liver. Food Chem. Toxicol. 1996, 34:33-42.
371. 2+. Mutat. Res. 1981, 90:355-363.
372. Maralhas A., Monteiro A., Martins C., Kranendonk M., Laires A., Rueff J., Rodrigues A.S. Genotoxicity and endoreduplication inducing activity of the food flavouring eugenol. Mutagenesis 2006, 21:199-204.
373. Phillips D.H. Further evidence that eugenol does not bind to DNA in vivo. Mutat. Res. 1990, 245:23-26.
374. Dillon D., Combes R., Zeiger E. The effectiveness of Salmonella strains TA100, TA102 and TA104 for detecting mutagenicity of some aldehydes and peroxides. Mutagenesis 1998, 13:19-26.
375. OECD SIDS. Initial Assessment Report for SIAM 16 on Menthols, UNEP Publications (2004) 1-296, (accessed 12.10.15). http://www.chem.unep.ch/irptc/sids/OECDSIDS/MENTHOLS.pdf.
376. Ivett J.L., Brown B.M., Rodgers C., Anderson B.E., Resnick M.A., Zeiger E. Chromosomal aberrations and sister chromatid exchange tests in Chinese hamster ovary cells in vitro. IV. Results with 15 chemicals. Environ. Mol. Mutagen. 1989, 14:165-187.
377. Murthy P.B., Ahmed M.M., Regu K. Lack of genotoxicity of menthol in chromosome aberration and sister chromatid exchange assays using human lymphocytes in vitro. Toxicol. In Vitro 1991, 5:337-340.
378. Shimizu M., Yano E. Mutagenicity of mono-nitrobenzene derivatives in the Ames test and Rec assay. Mutat. Res. 1986, 170:11-22.
379. Kawai A., Goto S., Matsumoto Y., Matsushita H. Mutagenicity of aliphatic and aromatic nitro compounds. Sangyo Igaku 1987, 29:34-55.
380. Dellarco V.L., Prival M.J. Mutagenicity of nitro compounds in Salmonella typhimurium in the presence of flavin mononucleotide in a preincubation assay. Environ. Mol. Mutagen. 1989, 13:116-127.
381. Concise International Chemical Assessment Document (CICAD) 20, Mononitrophenols, World Health Organisation, Geneva, 2000.
382. Eichenbaum G., Johnson M., Kirkland D., O'Neill P., Stellar S., Bielawne J., DeWire R., Areia D., Bryant S., Weiner S., Desai-Krieger D., Guzzie-Peck P., Evans D.C., Tonelli A. Assessment of the genotoxic and carcinogenic risks of p-nitrophenol when it is present as an impurity in a drug product. Regul. Tox. Pharm. 2009, 55:33-42.
383. Huang O.G., Kong L.R., Liu Y.B., Wang L.S. Relationships between molecular structure and chromosomal aberrations in in vitro human lymphocytes induced by substituted nitrobenzenes. Bull. Environ. Contam. Toxicol. 1996, 57:349-353.
384. Hageman G.J., Verhagen H., Kleinjans J.C. Butylated hydroxyanisole, butylated hydroxytoluene and tert-butylhydroquinone are not mutagenic in the Salmonella/microsome assay using new tester strains. Mutat. Res. 1988, 208:207-211.
385. Matsuoka A., Matsui M., Miyata N., Sofuni T., Ishidate M. Mutagenicity of 3-tert-butyl-4-hydroxyanisole (BHA) and its metabolites in short-term tests in vitro. Mutat. Res. 1990, 241:125-132.
386. Donner M., Husgafvel-Pursiainen K., Jenssen D., Rannug A. Mutagenicity of rubber additives and curing fumes. Results from five short-term bioassays. Scand. J. Work Environ. Health 1983, 9(Suppl. 2):27-37.
387. Shimizu H., Suzuki Y., Takemura N., Goto S., Matsushita H. The results of microbial mutation test for forty-three industrial chemicals. Sangyo Igaku 1985, 27:400-419.
388. Zhang Z., Dmitrieva N.I., Park J.H., Levine R.L., Burg M.B. High urea and NaCl carbonylate proteins in renal cells in culture and in vivo, and high urea causes 8-oxoguanine lesions in their DNA. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:9491-9496.
389. Waegemaekers T.H., Bensink M.P. Non-mutagenicity of 27 aliphatic acrylate esters in the Salmonella-microsome test. Mutat. Res. 1984, 137:95-102.
390. Przybojewska B., Dziubałtowska E., Kowalski Z. Genotoxic effects of ethyl acrylate and methyl acrylate in the mouse evaluated by the micronucleus test. Mutat. Res. 1984, 135:189-191.
391. Ashby J., Richardson C.R., Tinwell H. Inactivity of ethyl acrylate in the mouse bone marrow micronucleus assay. Mutagenesis 1989, 4:283-285.
392. Kligerman A.D., Atwater A.L., Bryant M.F., Erexson G.L., Kwanyuen P., Dearfield K.L. Cytogenetic studies of ethyl acrylate using C57BL/6 mice. Mutagenesis 1991, 6:137-141.
393. Moore M.M., Amtower A., Doerr C.L., Brock K.H., Dearfield K.L. Genotoxicity of acrylic acid, methyl acrylate, ethyl acrylate, methyl methacrylate, and ethyl methacrylate in L5178Y mouse lymphoma cells. Environ. Mol. Mutagen. 1988, 11:49-63.
394. Dearfield K.L., Harrington-Brock K., Doerr C.L., Rabinowitz J.R., Moore M.M. Genotoxicity in mouse lymphoma cells of chemicals capable of Michael addition. Mutagenesis 1991, 6:519-525.
395. H. Fujita, M. Sasaki, Mutagenicity test of food additives with Salmonella typhimurium TA97A and TA102, I, Kenkyu Nenpo - Tokyo-Toritsu Eisei Kenkyusho 37 (1986) 447-452.
396. Ashby J. The genotoxicity of sodium saccharin and sodium chloride in relation to their cancer-promoting properties. Food Chem. Toxicol. 1985, 23:507-519.
397. Maron D.M., Ames B.N. Revised methods for the Salmonella mutagenicity test. Mutat. Res. 1983, 113:173-215.